CypA was shown to reduce cellular reactive oxygen species levels and increase CRC cell survival when exposed to H2O2 and chemotherapeutics, mediated by a CypA-peroxiredoxin-2 (PRDX2) antioxidant mechanism. The gene discussed is PPIA; the disease is colorectal carcinoma.